Table 1.
Pretreatment Characteristics
| Characteristic | No. of Eligible Patients (N = 518) | % |
|---|---|---|
| Age, years | ||
| Median | 61 | |
| Range | 23-79 | |
| Sex | ||
| Male | 467 | 90 |
| Female | 51 | 10 |
| Race | ||
| White | 474 | 92 |
| Other | 44 | 9 |
| Primary site | ||
| Middle third | 11 | 2 |
| Lower third | 170 | 33 |
| Gastroesophageal junction | 337 | 65 |
| Histology | ||
| Adenocarcinoma | 518 | 100 |
| Histologic grade | ||
| Well to moderate | 230 | 44 |
| Poor | 287 | 55 |
| Unspecified | 1 | 0.2 |
| Pretreatment clinical stage | ||
| X* | 21 | 4 |
| I | 2 | 0.4 |
| II | 202 | 39 |
| III | 268 | 52 |
| IVa | 25 | 5 |
NOTE. Because of rounding, the total may not add up to 100%.
*
X could not be finalized.